“Manufacturers that I have spoken with estimate that 10% to 30% (or more) of patients that receive a prescription for a specialty drug do not start therapy because they cannot afford even the first prescription.”
— Bill Sullivan, principal consultant with Specialty Pharmacy Solutions LLC, told AIS’s Specialty Pharmacy News.
No comments:
Post a Comment